John Sundy

John Sundy

Direttore/Membro del Consiglio presso SANOFI
64 anni
Consumer Services
Health Technology
Technology Services

Profilo

John Sundy currently works at Sanofi, as Independent Director from 2024, Neutrolis, Inc., as Director, Childhood Arthritis & Rheumatology Research Alliance, as Director, and Seismic Therapeutic, Inc., as Chief Medical Officer from 2022.
Dr. Sundy also formerly worked at Gilead Sciences, Inc., as Senior Vice President from 2014 to 2020, Duke University, as Associate Professor from 2006 to 2014, Duke-NUS Graduate Medical School Singapore, as Associate Professor from 2006 to 2014, and Pandion Therapeutics, Inc., as Chief Medical Officer.
Dr. Sundy received his undergraduate degree from Bucknell University, doctorate degree from Drexel University College of Medicine, and doctorate degree from Hahnemann University.

Posizioni attive di John Sundy

SocietàPosizioneInizio
SANOFI Direttore/Membro del Consiglio 30/04/2024
Direttore/Membro del Consiglio -
Childhood Arthritis & Rheumatology Research Alliance
Direttore/Membro del Consiglio -
Direttore Tecnico/Scientifico/R&S 01/01/2022

Precedenti posizioni note di John Sundy

SocietàPosizioneFine
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/04/2020
Corporate Officer/Principal 01/01/2014
Corporate Officer/Principal 01/01/2014
PANDION THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S -
Vedi nel dettaglio l'esperienza di John Sundy

Formazione di John Sundy

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

99

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Technology Services

Childhood Arthritis & Rheumatology Research Alliance

  1. Mercati
  2. Insiders
  3. John Sundy
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA